These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19266264)

  • 1. Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.
    Kuder KJ; Ligneau X; Camelin JC; Lazewska D; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Inflamm Res; 2009 Apr; 58 Suppl 1():47-8. PubMed ID: 19266264
    [No Abstract]   [Full Text] [Related]  

  • 2. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.
    Ishikawa M; Furuuchi T; Yamauchi M; Yokoyama F; Kakui N; Sato Y
    Bioorg Med Chem; 2010 Jul; 18(14):5441-8. PubMed ID: 20541426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.
    Grassmann S; Apelt J; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    Arch Pharm (Weinheim); 2004 Oct; 337(10):533-45. PubMed ID: 15476285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
    Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
    Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
    Łazewska D; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 May; 14(10):3522-9. PubMed ID: 16466921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-acting diether derivatives of piperidine and homopiperidine with histamine H(3) receptor antagonistic and anticholinesterase activity.
    Bajda M; Kuder KJ; Lażewska D; Kieć-Kononowicz K; Więckowska A; Ignasik M; Guzior N; Jończyk J; Malawska B
    Arch Pharm (Weinheim); 2012 Aug; 345(8):591-7. PubMed ID: 22549828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
    Amon M; Ligneau X; Camelin JC; Berrebi-Bertrand I; Schwartz JC; Stark H
    ChemMedChem; 2007 May; 2(5):708-16. PubMed ID: 17361979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
    Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities.
    Amon M; Ligneau X; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1938-40. PubMed ID: 16434192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H
    Kuder KJ; Łażewska D; Kaleta M; Latacz G; Kottke T; Olejarz A; Karcz T; Fruziński A; Szczepańska K; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2017 May; 25(10):2701-2712. PubMed ID: 28372935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
    Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
    Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties.
    Kuder KJ; Kottke T; Stark H; Ligneau X; Camelin JC; Seifert R; Kieć-Kononowicz K
    Inflamm Res; 2010 Mar; 59 Suppl 2():S247-8. PubMed ID: 20091085
    [No Abstract]   [Full Text] [Related]  

  • 17. Biphenyloxy-alkyl-piperidine and azepane derivatives as histamine H
    Łażewska D; Kaleta M; Schwed JS; Karcz T; Mogilski S; Latacz G; Olejarz A; Siwek A; Kubacka M; Lubelska A; Honkisz E; Handzlik J; Filipek B; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2017 Oct; 25(20):5341-5354. PubMed ID: 28797771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent medicinal chemistry of the histamine H3 receptor.
    Letavic MA; Barbier AJ; Dvorak CA; Carruthers NI
    Prog Med Chem; 2006; 44():181-206. PubMed ID: 16697898
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluorinated non-imidazole histamine H3 receptor antagonists.
    Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists.
    Jitsuoka M; Tsukahara D; Ito S; Tanaka T; Takenaga N; Tokita S; Sato N
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5101-6. PubMed ID: 18768318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.